Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma

Frontiers in Oncology(2022)10.3389/fonc.2022.995027Source: DataRank Database

Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (17)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Lincoln N. Strickland ORCID,Baylee J. O’Brien ORCID,Joseph F. Barraza,Nirav Thosani ORCID,Curtis J. Wray ORCID

Live enrichment

PubMed:36147911 PMC:PMC9486545

NIAMS NIH HHS

Grant: R01 AR073284

National Institutes of Health

Grant: 5R01AR073284-04

CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis

National Institutes of Health

Grant: 1R21CA249924-01A1

Defining the role of Mst1/Mst2 in regulating metabolic alterations in Ras driven NSCLC

National Institutes of Health

Grant: 2P30DK056338-16

Texas Medical Center Digestive Diseases Center

National Institutes of Health

Office of Extramural Research, National Institutes of Health

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.995027/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.995027/full

repositoryhttps://doaj.org/article/b30922c3a0dc4527b8f6e36797cd0493

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9486545

Europe_PMChttps://europepmc.org/articles/PMC9486545

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

AdenosineInosinePancreatic cancerRadiofrequency AblationCd73Ab680Medical Sciences610Neoplasms. Tumors. Oncology. Including cancer and carcinogensOncologyMedical MicrobiologyMedical SpecialtiesMedicine and Health SciencesRC254-282

Sustainable Development Goals

SDG 3: 3. Good health